Polytetrafluoroethylene

Summary

Polytetrafluoroethylene (CHEMBL1201480) is an approved small molecule.

At a glance

• Status: Approved (max clinical phase 4)
• Modality: Small molecule
• Clinical trials: 5

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL1201480
Name	Polytetrafluoroethylene
Type	Small molecule
Max phase	4

Also known as: Polytetrafluoroethylene, POLYTETRAFLUOROETHYLENE

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

0 indications (0 at ChEMBL trial phase 4).

Clinical trials

Total trials: 5.

Phase distribution

Phase	Trials
Not specified	5

Top trials by phase / activity

NCT	Phase	Status	Title
NCT06746935	Not specified	RECRUITING	Reconstruction of Deficient Atrophic Ridges Using Guide Bone Regeneration Technique
NCT02277925	Not specified	COMPLETED	Permanent Versus Absorbable Colpopexy Trial
NCT02625597	Not specified	COMPLETED	Assessment of the Effects of Different Implant Abutment Occluding Materials on Dental Implant Health Parameters and Microbiology
NCT04234308	Not specified	UNKNOWN	Properties of Absorbable and Nonabsorbable Suture Material in Dental Surgery
NCT07573020	Not specified	COMPLETED	Influence of Acellular Dermal Matrix on Peri-implant Soft Tissue Phenotype and Marginal Bone Loss

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).